Bioventus (BVS) FCF Margin (QoQ) (2020 - 2026)
Bioventus (BVS) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 602.00 |
| Mar 28, 2026 | -1,732.00 |
| Dec 31, 2025 | 326.00 |
| Sep 27, 2025 | 243.00 |
| Jun 28, 2025 | 3,426.00 |
| Mar 29, 2025 | -2,827.00 |
| Dec 31, 2024 | 451.00 |
| Sep 28, 2024 | -259.00 |
| Jun 29, 2024 | 1,495.00 |
| Mar 30, 2024 | -1,252.00 |
| Dec 31, 2023 | 1,661.00 |
| Sep 30, 2023 | -1,872.00 |
| Jul 1, 2023 | 884.00 |
| Apr 1, 2023 | -750.00 |
| Dec 31, 2022 | 959.00 |
| Oct 1, 2022 | 25.00 |
| Jul 2, 2022 | 1,658.00 |
| Apr 2, 2022 | -2,118.00 |
| Dec 31, 2021 | -297.00 |
| Oct 2, 2021 | -912.00 |